Discovery & Development

New antibiotic candidate Clovibactin eliminates bacteria without developing resistance

Will our generation be the last to face untreatable Alzheimer’s disease? With predictive biomarkers and active immunotherapies, just maybe.

Here’s why virus-like particles could open a new chapter in combating disease.

Scientists are targeting EV-A71 RNA viruses using an adeno-associated virus-delivered CRISPR-Cas13 editor

In light of cabotegravir’s positive opinion for sexually acquired HIV-1, I wanted to explore the history and politics of HIV/AIDS drug development

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

Fungal infections and antifungal resistance are a significant problem; here’s one approach to consider

Researchers demonstrate that complex data analysis paired with artificial intelligence can predict additional causes of Teratogenicity

Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing

The more we learn about the complexity of Alzheimer’s, the more we need to change the way we treat it